To determine whether the effects of STZ treatment on the levels of fasting blood glucose and serum levels of insulin and GIP were repeatable, we employed 3xTg AD model mice, which also express 4R human tau (12) and their control WT mice. The gene discussed is MAPT; the disease is Alzheimer disease.